Recursion Pharma CFO on AI’s Disruption and Drug Development PartnershipsMarch 4, 2025 Ben Taylor, CFO of Recursion Pharmaceuticals, discusses the rise of AI in biopharma, the importance of commitment in partnerships, and the challenges of data usage.
